International Journal of Molecular and Immuno Oncology

Most Viewed Articles

Total Downloads
1,444,907
Fulltext
976,202
PDF
468,705

Articles	Fulltext downloads	PDF downloads	Total downloads
Short Communication Driver mutations in oncogenesis Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020	28,271	3,032	31,303
Review Article Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023	23,923	1,994	25,917
Original Article Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023	22,801	1,867	24,668
Editorial Challenging conventional wisdom in molecular oncology: New perspectives Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023	22,771	1,851	24,622
Review Article Molecular oncology and the role of artificial intelligence in advancing cancer treatment Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023	22,283	1,344	23,627
Short Communication Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020	18,770	2,553	21,323
Case Report *Long-term efficacy of osimertinib in de novo* exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India** Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_16_2023	19,238	1,462	20,700
News Editorial board tribute to Dr. Amit Verma Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December	14,970	1,945	16,915
Review Article Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022	12,556	4,249	16,805
Case Report Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022	11,562	4,881	16,443
Case Report Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023	14,023	1,765	15,788
Case Report Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_16_2021	13,640	1,712	15,352
Cardio Oncology with ACOS Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022	11,440	3,715	15,155
New Drug Update Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021	13,448	1,685	15,133
Review Article Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022	13,567	1,547	15,114
Review Article Potential therapeutic molecular targets for better outcomes for patients with lung cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022	14,430	681	15,111
Review Article Combination of PARPi and anti-PD-L1 therapies in ovarian cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022	14,205	883	15,088
Original Article Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change? Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022	10,914	3,751	14,665
Review Article Immune dynamics of SARS-CoV-2 virus evolution Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021	10,169	3,955	14,124
Case Series Dual driver in non-small cell lung carcinoma – therapeutic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2021	11,840	2,056	13,896
Review Article Is continuous infusion of high-dose ifosfamide, a safe option? Drug review Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019	10,963	2,872	13,835
Review Article Advances in immunotherapy for metastatic esophageal cancer Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022	10,009	3,751	13,760
Case Report L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023	12,328	1,049	13,377
Review Article Immuno-oncological era of breast cancer: A progressive path to better treatment Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022	8,612	4,697	13,309
Review Article The evolving role of precision medicine in the management of advanced sarcomas – A mini review Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021	11,305	1,994	13,299
Case Report Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_11_2022	10,683	2,348	13,031
Editorial Nanobytes Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2019	6,379	6,652	13,031
Review Article Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021	10,743	2,188	12,931
Review Article Immuno-oncology of differentiated thyroid cancer Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020	10,080	2,698	12,778
Editorial Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2024	11,166	1,493	12,659
Review Article High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_1_2024	11,498	1,075	12,573
Review Article Understanding immunotherapy and CAR-T-cells: A narrative review Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2023	11,376	1,155	12,531
Conference Review 6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2021	10,930	1,568	12,498
Brief Commentary ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021	10,314	2,181	12,495
Review Article A compendium of population wide DNA methylation profile for oral cancer in India Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021	9,402	3,031	12,433
Case Report Complete metabolic response with letrozole and palbociclib in advanced breast cancer Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019	7,903	4,512	12,415
Erratum Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020) Full text \| PDF Year: 2021, Volume: 6, Issue: 2, October DOI: 10.25259/IJMIO_05_2020_ER	11,230	1,154	12,384
Review Article Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2024	11,257	1,049	12,306
Case Report Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2021	10,548	1,724	12,272
Brief Commentary Breast cancer prognostic tools: A promising Indian option Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020	8,472	3,737	12,209
Original Article Spectrum of lymphomas in India Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2023	11,163	542	11,705
Brief Commentary Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2021	9,522	2,157	11,679
Letter to Editor Letter to editor Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_10_2022	7,959	3,700	11,659
Case Report Metastatic endometrial carcinoma responsive to pembrolizumab Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2020	6,747	4,886	11,633
Review Article Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022	7,412	4,171	11,583
Review Article Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2019	6,406	5,077	11,483
Review Article The Cancer Genomic Atlas – “TO CONQUER CANCER” Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020	8,905	2,474	11,379
Review Article *Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ* hybridization and Immunohistochemistry: A meta-analysis with systematic review** Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019	5,842	5,398	11,240
Review Article Molecular genetics changes in gallbladder carcinoma Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019	7,792	3,381	11,173
Original Article Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_1_2019	5,339	5,757	11,096

Most Viewed Articles

Driver mutations in oncogenesis

Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes

Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India

Challenging conventional wisdom in molecular oncology: New perspectives

Molecular oncology and the role of artificial intelligence in advancing cancer treatment

Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India

Editorial board tribute to Dr. Amit Verma

Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching

Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia

Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph

Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male

Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival

Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor

Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets

Potential therapeutic molecular targets for better outcomes for patients with lung cancer

Combination of PARPi and anti-PD-L1 therapies in ovarian cancer

Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?

Immune dynamics of SARS-CoV-2 virus evolution

Dual driver in non-small cell lung carcinoma – therapeutic dilemma

Is continuous infusion of high-dose ifosfamide, a safe option? Drug review

Advances in immunotherapy for metastatic esophageal cancer

L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report

Immuno-oncological era of breast cancer: A progressive path to better treatment

The evolving role of precision medicine in the management of advanced sarcomas – A mini review

Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report

Nanobytes

Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective

Immuno-oncology of differentiated thyroid cancer

Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer

High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective

Understanding immunotherapy and CAR-T-cells: A narrative review

6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning

A compendium of population wide DNA methylation profile for oral cancer in India

Complete metabolic response with letrozole and palbociclib in advanced breast cancer

Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)

Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article

Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma

Breast cancer prognostic tools: A promising Indian option

Spectrum of lymphomas in India

Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management

Letter to editor

Metastatic endometrial carcinoma responsive to pembrolizumab

Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications

Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology

The Cancer Genomic Atlas – “TO CONQUER CANCER”

Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review

Molecular genetics changes in gallbladder carcinoma

Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India

**Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India**

6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

**Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review**